West Pharmaceutical Services, Inc. (WST)
USD 211.29
(0.49%)
USD 211.29
(0.49%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -544.9 Million USD | 5.46% |
| 2022 | -576.4 Million USD | -31.81% |
| 2021 | -437.3 Million USD | -50.9% |
| 2020 | -289.8 Million USD | -163.93% |
| 2019 | -109.8 Million USD | 22.29% |
| 2018 | -141.3 Million USD | -263.24% |
| 2017 | -38.9 Million USD | -251.95% |
| 2016 | 25.6 Million USD | 8.47% |
| 2015 | 23.6 Million USD | -71.01% |
| 2014 | 81.4 Million USD | -43.28% |
| 2013 | 143.5 Million USD | -42.51% |
| 2012 | 249.6 Million USD | -3.11% |
| 2011 | 257.6 Million USD | 3.79% |
| 2010 | 248.2 Million USD | -16.29% |
| 2009 | 296.5 Million USD | -0.77% |
| 2008 | 298.8 Million USD | 4.22% |
| 2007 | 286.7 Million USD | 51.53% |
| 2006 | 189.2 Million USD | -18.52% |
| 2005 | 232.2 Million USD | 152.39% |
| 2004 | 92 Million USD | -32.94% |
| 2003 | 137.2 Million USD | -3.24% |
| 2002 | 141.8 Million USD | -6.03% |
| 2001 | 150.9 Million USD | -3.7% |
| 2000 | 156.7 Million USD | 24.56% |
| 1999 | 125.8 Million USD | 14.57% |
| 1998 | 109.8 Million USD | 199.18% |
| 1997 | 36.7 Million USD | -48.31% |
| 1996 | 71 Million USD | -26.73% |
| 1995 | 96.9 Million USD | 216.67% |
| 1994 | 30.6 Million USD | 12.92% |
| 1993 | 27.1 Million USD | -30.69% |
| 1992 | 39.1 Million USD | -29.8% |
| 1991 | 55.7 Million USD | -27.0% |
| 1990 | 76.3 Million USD | 35.04% |
| 1989 | 56.5 Million USD | 13.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -288.3 Million USD | -40.77% |
| 2024 Q1 | -295.2 Million USD | 45.82% |
| 2024 Q2 | -132.2 Million USD | 55.22% |
| 2023 Q2 | -485 Million USD | 15.19% |
| 2023 FY | -544.9 Million USD | 5.46% |
| 2023 Q1 | -571.9 Million USD | 0.78% |
| 2023 Q3 | -591.8 Million USD | -22.02% |
| 2023 Q4 | -544.9 Million USD | 7.92% |
| 2022 Q1 | -336.5 Million USD | 23.05% |
| 2022 FY | -576.4 Million USD | -31.81% |
| 2022 Q4 | -576.4 Million USD | -34.33% |
| 2022 Q3 | -429.1 Million USD | -11.17% |
| 2022 Q2 | -386 Million USD | -14.71% |
| 2021 FY | -437.3 Million USD | -50.9% |
| 2021 Q4 | -437.3 Million USD | -17.43% |
| 2021 Q3 | -372.4 Million USD | -45.02% |
| 2021 Q2 | -256.8 Million USD | -58.23% |
| 2021 Q1 | -162.3 Million USD | 44.0% |
| 2020 Q4 | -289.8 Million USD | -49.46% |
| 2020 Q1 | -8 Million USD | 92.71% |
| 2020 Q3 | -193.9 Million USD | -62.94% |
| 2020 Q2 | -119 Million USD | -1387.5% |
| 2020 FY | -289.8 Million USD | -163.93% |
| 2019 Q4 | -109.8 Million USD | 13.95% |
| 2019 FY | -109.8 Million USD | 22.29% |
| 2019 Q1 | 7.6 Million USD | 105.38% |
| 2019 Q2 | -54.1 Million USD | -811.84% |
| 2019 Q3 | -127.6 Million USD | -135.86% |
| 2018 Q4 | -141.3 Million USD | -39.76% |
| 2018 Q2 | -29.1 Million USD | -1516.67% |
| 2018 Q3 | -101.1 Million USD | -247.42% |
| 2018 Q1 | -1.8 Million USD | 95.37% |
| 2018 FY | -141.3 Million USD | -263.24% |
| 2017 Q2 | 2.9 Million USD | -95.1% |
| 2017 FY | -38.9 Million USD | -251.95% |
| 2017 Q4 | -38.9 Million USD | 1.52% |
| 2017 Q3 | -39.5 Million USD | -1462.07% |
| 2017 Q1 | 59.2 Million USD | 131.25% |
| 2016 Q2 | 28.7 Million USD | -46.75% |
| 2016 FY | 25.6 Million USD | 8.47% |
| 2016 Q4 | 25.6 Million USD | 1.19% |
| 2016 Q3 | 25.3 Million USD | -11.85% |
| 2016 Q1 | 53.9 Million USD | 128.39% |
| 2015 FY | 23.6 Million USD | -71.01% |
| 2015 Q2 | 74.7 Million USD | -39.56% |
| 2015 Q1 | 123.6 Million USD | 51.84% |
| 2015 Q4 | 23.6 Million USD | -48.36% |
| 2015 Q3 | 45.7 Million USD | -38.82% |
| 2014 Q2 | 134.8 Million USD | -22.93% |
| 2014 FY | 81.4 Million USD | -43.28% |
| 2014 Q4 | 81.4 Million USD | -15.12% |
| 2014 Q1 | 174.9 Million USD | 21.88% |
| 2014 Q3 | 95.9 Million USD | -28.86% |
| 2013 FY | 143.5 Million USD | -42.51% |
| 2013 Q3 | 178.3 Million USD | -12.68% |
| 2013 Q2 | 204.2 Million USD | -19.95% |
| 2013 Q1 | 255.1 Million USD | 2.2% |
| 2013 Q4 | 143.5 Million USD | -19.52% |
| 2012 FY | 249.6 Million USD | -3.11% |
| 2012 Q4 | 249.6 Million USD | -3.33% |
| 2012 Q3 | 258.2 Million USD | -7.29% |
| 2012 Q2 | 278.5 Million USD | -0.96% |
| 2012 Q1 | 281.2 Million USD | 9.16% |
| 2011 Q3 | 258.8 Million USD | -1.63% |
| 2011 Q1 | 276.4 Million USD | 11.36% |
| 2011 Q4 | 257.6 Million USD | -0.46% |
| 2011 FY | 257.6 Million USD | 3.79% |
| 2011 Q2 | 263.1 Million USD | -4.81% |
| 2010 FY | 248.2 Million USD | -16.29% |
| 2010 Q1 | 303.5 Million USD | 2.36% |
| 2010 Q2 | 289.7 Million USD | -4.55% |
| 2010 Q3 | 273.6 Million USD | -5.56% |
| 2010 Q4 | 248.2 Million USD | -9.28% |
| 2009 Q2 | 305.9 Million USD | -5.93% |
| 2009 Q3 | 317.5 Million USD | 3.79% |
| 2009 Q4 | 296.5 Million USD | -6.61% |
| 2009 Q1 | 325.2 Million USD | 8.84% |
| 2009 FY | 296.5 Million USD | -0.77% |
| 2008 FY | 298.8 Million USD | 4.22% |
| 2008 Q1 | 323.9 Million USD | 12.98% |
| 2008 Q3 | 280 Million USD | -5.37% |
| 2008 Q4 | 298.8 Million USD | 6.71% |
| 2008 Q2 | 295.9 Million USD | -8.64% |
| 2007 Q3 | 242.2 Million USD | 16.78% |
| 2007 Q4 | 286.7 Million USD | 18.37% |
| 2007 Q2 | 207.4 Million USD | -5.94% |
| 2007 Q1 | 220.5 Million USD | 16.54% |
| 2007 FY | 286.7 Million USD | 51.53% |
| 2006 Q1 | 239.7 Million USD | 3.23% |
| 2006 Q3 | 196.3 Million USD | -8.19% |
| 2006 Q4 | 189.2 Million USD | -3.62% |
| 2006 FY | 189.2 Million USD | -18.52% |
| 2006 Q2 | 213.8 Million USD | -10.81% |
| 2005 Q1 | 98.7 Million USD | 7.28% |
| 2005 FY | 232.2 Million USD | 152.39% |
| 2005 Q2 | 216.5 Million USD | 119.35% |
| 2005 Q3 | 239.7 Million USD | 10.72% |
| 2005 Q4 | 232.2 Million USD | -3.13% |
| 2004 Q3 | 99.4 Million USD | -5.42% |
| 2004 FY | 92 Million USD | -32.94% |
| 2004 Q1 | 111.6 Million USD | -18.66% |
| 2004 Q2 | 105.1 Million USD | -5.82% |
| 2004 Q4 | 92 Million USD | -7.44% |
| 2003 Q4 | 137.2 Million USD | 10.29% |
| 2003 Q2 | 135.3 Million USD | -0.88% |
| 2003 Q3 | 124.4 Million USD | -8.06% |
| 2003 Q1 | 136.5 Million USD | -3.74% |
| 2003 FY | 137.2 Million USD | -3.24% |
| 2002 Q3 | 142.4 Million USD | -9.47% |
| 2002 Q2 | 157.3 Million USD | -0.13% |
| 2002 FY | 141.8 Million USD | -6.03% |
| 2002 Q4 | 141.8 Million USD | -0.42% |
| 2002 Q1 | 157.5 Million USD | 4.37% |
| 2001 Q1 | 171.3 Million USD | 9.32% |
| 2001 Q4 | 150.9 Million USD | -15.37% |
| 2001 FY | 150.9 Million USD | -3.7% |
| 2001 Q3 | 178.3 Million USD | 4.45% |
| 2001 Q2 | 170.7 Million USD | -0.35% |
| 2000 FY | 156.7 Million USD | 24.56% |
| 2000 Q4 | 156.7 Million USD | 3.84% |
| 2000 Q3 | 150.9 Million USD | 2.51% |
| 2000 Q1 | 75.7 Million USD | -39.83% |
| 2000 Q2 | 147.2 Million USD | 94.45% |
| 1999 FY | 125.8 Million USD | 14.57% |
| 1999 Q3 | 126.1 Million USD | 0.24% |
| 1999 Q4 | 125.8 Million USD | -0.24% |
| 1999 Q2 | 125.8 Million USD | 17.24% |
| 1999 Q1 | 107.3 Million USD | -2.28% |
| 1998 Q1 | 59.4 Million USD | 61.85% |
| 1998 Q2 | 63 Million USD | 6.06% |
| 1998 Q3 | 62.7 Million USD | -0.48% |
| 1998 Q4 | 109.8 Million USD | 75.12% |
| 1998 FY | 109.8 Million USD | 199.18% |
| 1997 Q3 | 37.3 Million USD | -24.8% |
| 1997 Q1 | 64 Million USD | -9.86% |
| 1997 Q2 | 49.6 Million USD | -22.5% |
| 1997 Q4 | 36.7 Million USD | -1.61% |
| 1997 FY | 36.7 Million USD | -48.31% |
| 1996 FY | 71 Million USD | -26.73% |
| 1996 Q4 | 71 Million USD | -17.25% |
| 1996 Q1 | 94.2 Million USD | -2.79% |
| 1996 Q3 | 85.8 Million USD | -15.05% |
| 1996 Q2 | 101 Million USD | 7.22% |
| 1995 Q2 | 109 Million USD | 94.99% |
| 1995 Q1 | 55.9 Million USD | 82.68% |
| 1995 Q4 | 96.9 Million USD | -5.37% |
| 1995 FY | 96.9 Million USD | 216.67% |
| 1995 Q3 | 102.4 Million USD | -6.06% |
| 1994 Q2 | 38.1 Million USD | 30.03% |
| 1994 Q3 | 34.9 Million USD | -8.4% |
| 1994 Q4 | 30.6 Million USD | -12.32% |
| 1994 FY | 30.6 Million USD | 12.92% |
| 1994 Q1 | 29.3 Million USD | 8.12% |
| 1993 Q2 | 38.2 Million USD | 5.23% |
| 1993 FY | 27.1 Million USD | -30.69% |
| 1993 Q4 | 27.1 Million USD | -24.51% |
| 1993 Q3 | 35.9 Million USD | -6.02% |
| 1993 Q1 | 36.3 Million USD | -7.16% |
| 1992 Q2 | 49.5 Million USD | -10.49% |
| 1992 Q4 | 39.1 Million USD | -18.71% |
| 1992 FY | 39.1 Million USD | -29.8% |
| 1992 Q3 | 48.1 Million USD | -2.83% |
| 1992 Q1 | 55.3 Million USD | -0.72% |
| 1991 Q3 | 62.1 Million USD | -9.34% |
| 1991 Q4 | 55.7 Million USD | -10.31% |
| 1991 Q1 | 78.8 Million USD | 3.28% |
| 1991 FY | 55.7 Million USD | -27.0% |
| 1991 Q2 | 68.5 Million USD | -13.07% |
| 1990 Q1 | 62.2 Million USD | 10.09% |
| 1990 Q2 | 70.6 Million USD | 13.5% |
| 1990 Q4 | 76.3 Million USD | 2.14% |
| 1990 Q3 | 74.7 Million USD | 5.81% |
| 1990 FY | 76.3 Million USD | 35.04% |
| 1989 FY | 56.5 Million USD | 13.0% |
| 1989 Q4 | 56.5 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alcon Inc. | 4.04 Billion USD | 113.456% |
| AptarGroup, Inc. | 961.03 Million USD | 156.699% |
| Baxter International Inc. | 11.16 Billion USD | 104.88% |
| Becton, Dickinson and Company | 14.46 Billion USD | 103.768% |
| Bausch + Lomb Corporation | 4.23 Billion USD | 112.879% |
| Haemonetics Corporation | 695.08 Million USD | 178.393% |
| Envista Holdings Corp | 713.6 Million USD | 176.359% |
| ResMed Inc. | 635.57 Million USD | 185.734% |
| Teleflex Incorporated | 1.7 Billion USD | 131.987% |
| Warby Parker Inc. | -42.43 Million USD | -1184.021% |